Chronic Stable Angina Clinical Trial
Official title:
Gut Flora Modulation for The Prevention of Pci-Related Myocardial Injury - A Randomized, Placebo Controlled, Double Blind, Investigator-Initiated, Single Centre, Preliminary Study
MYDA-MI study is a randomized, placebo controlled, double blind study performed in San Filippo Neri Hospital, Roma, Italy. The planned study duration is 18 months. The objectives are to assess the effects of pre-treatment with probiotic Ecoviesel on the incidence and magnitude of peri-procedural myocardial damage caused by coronary angioplasty in stable patients. 250 patients with chronic stable angina scheduled for a coronary angiography and possible ad hoc angioplasty will be randomized to receive pre-treatment with Ecoviesel sachets (each sachet contains 200 billions bacteria) or Placebo. The pre-treatment dosage will be 4 sachets of probiotic Ecoviesel or placebo for at least 2 weeks before the planned procedure. In patients undergoing angioplasty the same treatment will be continued for 4 weeks after PCI with secondary outcome measures performed at the end of this second stage.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT01397994 -
Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.
|
Phase 4 | |
| Active, not recruiting |
NCT00350922 -
A Clinical Trial of a Self-Management Education Program for People With Chronic Stable Angina
|
Phase 1 | |
| Completed |
NCT02078921 -
The Effects of Inorganic Nitrate on Cardiac Muscle in Angina
|
Phase 2 | |
| Completed |
NCT02591758 -
Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascularization or Medical Therapy
|
||
| Terminated |
NCT03346278 -
Text Message Intervention to Improve Cardiac Rehab Participation
|
N/A | |
| Active, not recruiting |
NCT06249581 -
Pharmacokinetics of AUX-001 40mg Once-daily in Healthy Subjects Under Fasting and Fed Conditions
|
Early Phase 1 | |
| Enrolling by invitation |
NCT03063697 -
Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure
|
N/A | |
| Completed |
NCT01239511 -
Phase IIb Study of STA-2 in Patients With Chronic Stable Angina
|
Phase 2 | |
| Completed |
NCT02722213 -
Mindfulness & Stress Management Study for Cardiac Patients
|
N/A | |
| Completed |
NCT01484912 -
Phase II Study of STA-2 in Patients With Chronic Stable Angina
|
Phase 2 | |
| Recruiting |
NCT03507361 -
Myocardial Damage and Music Study
|
N/A | |
| Recruiting |
NCT03834155 -
Enhancing Cardiac Rehabilitation Through Behavioral Nudges
|
N/A | |
| Active, not recruiting |
NCT02710435 -
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
|
||
| Withdrawn |
NCT00518921 -
Capadenoson in Angina Pectoris
|
Phase 2 | |
| Withdrawn |
NCT02423265 -
Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries
|
Phase 4 | |
| Completed |
NCT01369472 -
Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule
|
Phase 1 | |
| Completed |
NCT01340248 -
A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers
|
Phase 1 | |
| Completed |
NCT02315001 -
Liraglutide to Improve corONary Haemodynamics During Exercise streSS
|
Phase 2 | |
| Completed |
NCT01760083 -
A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions
|
N/A | |
| Unknown status |
NCT01558830 -
Safety of Amiodarone and Ranolazine Together in Patients With Angina
|
Phase 4 |